<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Sydney_Australia_Improve skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Sydney Australia/Improve</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="navbar navbar-inverse navbar-fixed-top" style="margin-top:15px;"><DIV class="container"><DIV class="navbar-collapse collapse"><UL class="nav navbar-nav navbar-right"><LI class="dropdown"><A class="dropdown-toggle" href="https://2017.igem.org/Team:Sydney_Australia/Team">Team </A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Team">About Us</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Attributions">Attributions</A></LI></UL><LI class="dropdown"><A class="dropdown-toggle" href="https://2017.igem.org/Team:Sydney_Australia/Design">Design </A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Design">Project Design</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Applied_Design">Applied Design</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/HP/Gold_Integrated">Integrated Human Practices</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Entrepreneurship">Entrepreneurship</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Patent_Law">Patent Law</A></LI><LI class="dropdown"><A class="dropdown-toggle" href="https://2017.igem.org/Team:Sydney_Australia/Description">Project </A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Description">Description</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Experiments">Protocols</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Safety">Safety</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Notebook">Notebook</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Results">Results</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Demonstrate">Demonstrate</A></LI><LI class="dropdown"><A class="dropdown-toggle" href="https://2017.igem.org/Team:Sydney_Australia/Model">Model </A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Model">Our Modelling</A></LI><LI class="dropdown"><A class="dropdown-toggle" href="https://2017.igem.org/Team:Sydney_Australia/Human_Practices">Communications </A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/HP/Silver">Human Practices</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Engagement">Engagement</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Collaborations">Collaborations</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Interlab">Interlab</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Rate_My_Gel">Rate My Gel</A></LI><LI class="dropdown"><A class="dropdown-toggle" href="https://2017.igem.org/Team:Sydney_Australia/Parts">Parts </A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Parts">Our Parts</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Composite_Part">Our Composite Parts</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Basic_Part">Our Basic Parts</A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Improve">Part Improvement</A></LI><LI class="dropdown"><A class="dropdown-toggle" href="https://2017.igem.org/Team:Sydney_Australia/Medals">Medals </A></LI><LI><A href="https://2017.igem.org/Team:Sydney_Australia/Medals"> Medals</A></LI></DIV></DIV></DIV><DIV class="container-fluid"><DIV class="row"><DIV class="para_container"><H2>Old Parts</H2><H4>Parts <A href="http://parts.igem.org/Part:BBa_M39904">BBa_M39904</A> and <A href="http://parts.igem.org/Part:BBa_M1877">BBa_M1877</A> were pre-existing registry parts described as ‘Human Insulin cDNA’ and ‘human insulin’ respectively. </H4></DIV></DIV><DIV class="row"><DIV class="para_container"><H2>What we Improved</H2><DIV class="col-xs-4"><H4>Part BBa_M39904 (Figure 1) consisted of 345 base pairs and was submitted as a basic part, and showed no differentiation between A and B chains, or if there was a C-peptide present.</H4><H4>Part BBa_M1877 (Figure 2) consisted of only 12bp and so was clearly unfinished.</H4></DIV><DIV class="col-xs-8"><FIGURE><FIGCAPTION>Figure 1: BBa_M39904 sequence as displayed in registry. The part is not compatible with many biobricks, and has no differentiation between A and B peptides.</FIGCAPTION></FIGURE><FIGURE><FIGCAPTION>Figure 2: BBa_M1877 sequence as displayed in registry. As human insulin is clearly more than 12bp this sequence was deemed incomplete.</FIGCAPTION></FIGURE></DIV></DIV></DIV><DIV class="row"><DIV class="para_container"><H2>Our Improved Parts</H2><H4> We submitted <A href="http://parts.igem.org/Part:BBa_K2417000">BBa_K2417000</A>, <A href="http://parts.igem.org/Part:BBa_K2417001">BBa_K2417001</A> and <A href="http://parts.igem.org/Part:BBa_K2417006">BBa_K2417006</A> as improvements upon these (Figure 3).</H4><FIGURE><FIGCAPTION>Figure 3: BBa_K2417000 – Ecotin-Proinsulin, BBa_K2417001 – Cytoplasmic-Proinsulin, BBa_K241006 - Proinsulin – are all improvement parts because they are much more clearly characterized and contains features for more efficient production and purification.</FIGCAPTION></FIGURE></DIV></DIV><DIV class="row"><H2>Summary</H2><DIV style="overflow-x:auto;"><TABLE style="width:80%;margin:auto;"><TBODY><TR><TH>Previous Part</TH><TH align="left">Characteristic</TH><TH align="left">How did we improve this?</TH><TH align="left">Which parts did we submit with this improvement?</TH></TR><TR><TD style="padding:1%">BBa_M399</TD><TD>Basic part</TD><TD>We submitted composite parts that clearly distinguish between A and B chains, and the presence of a C peptide. The use of a composite part submission system allows users to access the basic parts they consist of for more detailed information.</TD><TD>BBa_K2417000
BBa_K2417001
</TD></TR><TR><TD>Lacking complete sequence</TD><TD>Our parts are sequence verified, confirmed as complete and are based off NCBI sequences of human proinsulin.</TD><TD>BBa_K2417000
BBa_K2417001
BBa_K2417006
</TD></TR><TR><TD>Lacking ribosomal binding site</TD><TD>Our parts contain an efficient extended ribosomal binding site (part BBa_K2417009) which aids successful expression.</TD><TD>BBa_K2417000
BBa_K2417001
BBa_K2417006

</TD></TR><TR><TD>Lack of purification tags</TD><TD>We added an N-terminal His-tag (BBa_K2417008) to all of our proinsulin constructs to aid ease of purification. A His-tag allows purification using an affinity chromatography column.</TD><TD>BBa_K2417000
BBa_K2417001
BBa_K2417006

</TD></TR><TR><TD>No secretion tags</TD><TD>For some of our constructs we added tags to induce secretion of the protein to different parts of the cell. The addition of Ecotin to the N-terminus of proinsulin has been shown to induce its transport into the periplasm of E. coli, an oxidative environment favourable for the folding of disulphide bonds.</TD><TD>BBa_K2417000

</TD></TR><TR><TD>BBa_M39904</TD><TD>Biobrick incompatible</TD><TD>The construct entered into the database is only compatible with a single biobrick. All of our parts are compatible with all biobrick constructs.</TD><TD>BBa_K2417000
BBa_K2417001
BBa_K2417006

</TD></TR></TBODY></TABLE></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>